Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sprott (SII) Cash & Equivalents (2019 - 2026)

Sprott's Cash & Equivalents history spans 8 years, with the latest figure at $168.5 million for Q1 2026.

  • On a quarterly basis, Cash & Equivalents rose 201.66% to $168.5 million in Q1 2026 year-over-year; TTM through Mar 2026 was $168.5 million, a 201.66% increase, with the full-year FY2025 number at $123.4 million, up 163.58% from a year prior.
  • Cash & Equivalents hit $168.5 million in Q1 2026 for Sprott, up from $123.4 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for SII hit a ceiling of $168.5 million in Q1 2026 and a floor of $20.2 million in Q2 2023.
  • Historically, Cash & Equivalents has averaged $56.1 million across 5 years, with a median of $47.0 million in 2023.
  • Biggest five-year swings in Cash & Equivalents: plummeted 60.03% in 2023 and later soared 201.66% in 2026.
  • Tracing SII's Cash & Equivalents over 5 years: stood at $51.7 million in 2022, then plummeted by 60.03% to $20.7 million in 2023, then soared by 126.71% to $46.8 million in 2024, then soared by 163.58% to $123.4 million in 2025, then surged by 36.53% to $168.5 million in 2026.
  • Business Quant data shows Cash & Equivalents for SII at $168.5 million in Q1 2026, $123.4 million in Q4 2025, and $79.9 million in Q3 2025.